WallStreetZenWallStreetZen

NASDAQ: RDHL
Redhill Biopharma Revenue

OverviewEarningsRevenue
DividendOwnership
Redhill Biopharma revenue was $8.04M for the trailing 12 months ending Dec 31, 2024, with -100% growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was N/A, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, RDHL annual revenue was $8.0M, with 23.2% growth year-over-year.

RDHL past revenue growth

How has RDHL's revenue growth performed historically?

Company
23.17%
Industry
10.09%
Market
20.27%
RDHL's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
RDHL's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
RDHL's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

RDHL revenue history

Current Revenue
$8.0M
Current Earnings
-$8.3M
Current Profit Margin
-102.8%

Be the first to know when RDHL announces revenue.

RDHL Revenue History By Year

RDHL Yearly RevenueRDHL RevenueRDHL ChangeRDHL Revenue Growth
2024-12-31$8.04M$1.51M+23.17%
2023-12-31$6.53M-$55.27M-89.43%
2022-12-31$61.80M-$23.96M-27.94%
2021-12-31$85.76M$21.40M+33.25%
2020-12-31$64.36M$58.07M+923.03%
2019-12-31$6.29M-$2.07M-24.75%
2018-12-31$8.36M$4.35M+108.63%
2017-12-31$4.01M$3.91M+3,867.33%
2016-12-31$101.00k$98.00k+3,266.67%
2015-12-31$3.00k-$7.01M-99.96%
2014-12-31$7.01M$7.00M+58,350.00%
2013-12-30$12.00k-$4.00k-25.00%
2012-12-31$16.00k-$7.00k-30.43%
2011-12-31$23.00kN/AN/A
2010-12-31$0.00N/AN/A

1 of 1

Redhill Biopharma Revenue FAQ

What was RDHL's revenue last quarter?

Redhill Biopharma (NASDAQ: RDHL) reported Q4 2024 revenue of N/A up N/A year over year. In the same quarter last year, Redhill Biopharma's revenue was N/A.

What was Redhill Biopharma's revenue in 2024?

Redhill Biopharma's annual revenue for the twelve months ending Dec 31, 2024 was $8.04 million, a 23.17% increase year over year.

How much does Redhill Biopharma make in a day?

Based on Redhill Biopharma annual revenue for the past five years, RDHL makes an average of $124,103.56 per day.

What was Redhill Biopharma's annual revenue growth in the past year?

As of Q2 2025, Redhill Biopharma's revenue has grown 23.17% year over year. This is 13.08 percentage points higher than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 10.09%. Redhill Biopharma's revenue in the past year totaled $8.04 million.

How much does Redhill Biopharma make in a year?

Redhill Biopharma's revenue by year for the past five years is:
  • Redhill Biopharma's revenue for the twelve months ending Dec 31, 2024 was $8.04 million, a 23.17% increase year over year.
  • Redhill Biopharma's annual revenue for Dec 31, 2023 was $6.53 million, a 89.43% decrease from 2022.
  • Redhill Biopharma's annual revenue for 2022 was $61.80 million, a 27.94% decrease from 2021.
  • Redhill Biopharma's annual revenue for 2021 was $85.76 million, a 33.25% increase from 2020.
  • Redhill Biopharma's annual revenue for 2020 was $64.36 million, a 923.03% increase from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.